EP Patent

EP1381619B1 — 8-(c-beta-d-glucopyranosyl)-7,3',4'-trihydroxyflavone, process of isolation from pterocarpus marsupium and pharmaceutical composition for treatment of diabetes

Assigned to Council of Scientific and Industrial Research CSIR · Expires 2005-01-12 · 21y expired

What this patent protects

Patent listed against Zepatier.

Drugs covered by this patent

Patent Metadata

Patent number
EP1381619B1
Jurisdiction
EP
Classification
—
Expires
2005-01-12
Drug substance claim
No
Drug product claim
No
Assignee
Council of Scientific and Industrial Research CSIR
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.